Delivery Order SPE2DB22D2206-SPE2DB24FFX37
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price contract, valued at $1,382.46, has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,876.35 firm fixed price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp also holds a separate indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The $2,728.01 firm-fixed-price delivery order was awarded on June 28, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,520.06 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The delivery order has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract is a firm fixed price delivery order with a ceiling value of $3,672.84 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no indicated set-aside designation. In addition to this specific...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,525.82 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, with a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, valued at $1,883.86, was awarded by the Defense Logistics Agency (DLA) on June 20, 2024, with a completion date of June 21, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,000.90 firm fixed price delivery order is for the supply of the pharmaceutical product AIMOVIG 70 MG/ML AUTOINJECTORML. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,895.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 1, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,078.25 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a performance period through March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. This delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFX37Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $1,743.29 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/4/24 |